Agenda Details

Learn more about sessions and presentations at the 25th Annual Meeting

Detailed Program

Part 2: Translating Science Into Medicine: Moving from Bench to Startup (Organized by the Bioindustry & Translational Science Committees)

Now in Part 2 we want to hear from those who’ve done it across different cell and gene therapy modalities. Each panelist will address the following: what data they had when they spun-out, how they licensed their technology from the university (or in-licensed), how they structured their initial team, what data they still needed in for proof of concept, executing their IND-enabling studies, how they financed their first IND and clinical trial, and key lessons from those critical first years.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.